Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study-Reference-Cited by-同舟云学术

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

Published:2007-11 Issue:11 Volume:8 Page:975-984
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Rixe Olivier,Bukowski Ronald M,Michaelson M Dror,Wilding George,Hudes Gary R,Bolte Oliver,Motzer Robert J,Bycott Paul,Liau Katherine F,Freddo James,Trask Peter C,Kim Sinil,Rini Brian I

Publisher

Elsevier BV

Subject

Oncology

Reference18 articles.

1. Cancer statistics. 2006;Jemal;CA Cancer J Clin,2006

2. Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma;Motzer;J Clin Oncol,2000

3. Do cytokines improve survival in patients with metastatic renal cell carcinoma (MRCC) of intermediate prognostis? Results of the prospective randomized PERCY Quattro trial;Negrier;J Clin Oncol,2005

4. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2004

5. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma;Rini;J Clin Oncol,2005

Cited by 405 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of endothelin ETA receptors in the hypertension induced by the VEGFR-2 kinase inhibitors axitinib and lenvatinib in conscious freely-moving rats;Biochemical Pharmacology;2023-12

2. Nephrotoxicity of combination drug therapy in metastatic renal cancer;Cancer Urology;2023-11-16

3. Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata;British Journal of Cancer;2023-09-08

4. Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms;Science Translational Medicine;2023-06-14

5. The Clinical Impact of Vascular Endothelial Growth Factor/Receptor (VEGF/R) Inhibitors on Voice;Case Reports in Otolaryngology;2023-04-01